Medicine and Dentistry
Biological Product
100%
Metastatic Breast Cancer
100%
DNA A
100%
Mammaglobin A
100%
DNA Immunization
100%
Progression Free Survival
40%
Cytotoxic T-Cell
40%
T-Cell Response
30%
Flow Cytometry
20%
Breast Cancer
20%
Enzyme Linked Immunospot Assay
20%
Clinical Trial
10%
Adverse Event
10%
Metastatic Carcinoma
10%
T Cell
10%
Breast Cancer Prevention
10%
Clinical Assessment
10%
Cytotoxicity Assay
10%
Laboratory Assessment
10%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Product
100%
Metastatic Breast Cancer
100%
Mammaglobin A
100%
DNA A
100%
DNA Immunization
100%
Progression Free Survival
40%
CD8 Antigen
40%
Breast Cancer
30%
Flow Cytometry
20%
Clinical Trial
10%
Adverse Event
10%
Metastasis
10%
Cytotoxicity Assay
10%
Keyphrases
Metastatic Breast Cancer
100%
DNA Vaccine
100%
Mammaglobin
100%
Progression-free Survival
40%
CD8+ T Cell Response
30%
ELISPOT
20%
Adverse Events
10%
T Cells
10%
Vaccination
10%
Flow Cytometry
10%
Kaplan-Meier
10%
CD8+ T Cells
10%
Phase I Clinical Trial
10%
Metastatic Disease
10%
Clinical Assessment
10%
Breast Cancer Prevention
10%
HLA-A2
10%
Product-limit Estimator
10%
Response to Vaccination
10%
Primary Breast Cancer
10%
Patients with Breast Cancer
10%
Flow Cytometry Assay
10%
Cytotoxicity Assay
10%
Laboratory Assessment
10%
HLA Phenotypes
10%
Immunology and Microbiology
Biological Product
100%
DNA Immunization
100%
Cytotoxic T-Cell
66%
Progression Free Survival
66%
ELISPOT
33%
T Cell
16%
Cytotoxicity
16%